Howard Capital Management Group’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
DLA
ETC
Howard Capital Management Group's BMY Position: Q2 2026 in Review
Howard Capital Management Group held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 3,455 shares worth $199K. The position accounts for 0.01% of the portfolio, ranked #137.
Howard Capital Management Group first reported a position in BMY in Q1 2021 and has held it in 19 quarters since. The position peaked at $394K in Q3 2025. 800 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Howard Capital Management Group held 3,455 shares of Bristol-Myers Squibb worth $199K as of Q2 2026.
- Howard Capital Management Group left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.01% of Howard Capital Management Group's portfolio in Q2 2026, its #137 holding.
- Howard Capital Management Group first reported a position in Bristol-Myers Squibb in Q1 2021 and has held it in 19 quarters since.
- Howard Capital Management Group's Bristol-Myers Squibb position peaked at $394K in Q3 2025.
- 800 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Howard Capital Management Group's 13F filing for Q2 2026, filed 16 Jul 2026.